HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials. (2015)
Attributed to:
Managing and exploiting high dimensionality in genetic epidemiology
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(14)61183-1
PubMed Identifier: 25262344
Publication URI: http://europepmc.org/abstract/MED/25262344
Type: Journal Article/Review
Volume: 385
Parent Publication: Lancet (London, England)
Issue: 9965
ISSN: 0140-6736